Description
Anisotropine methylbromide is a muscarinic antagonist and antispasmodic. It was an adjunct in the treatment of peptic ulcer and promoted as being more specific to the gastrointestinal tract than other anticholinergics. But now, anisotropine methylbromide has been superseded by more effective agents in the treatment of peptic ulcer disease.
Synonyms
[(1S,5R)-8,8-dimethyl-8-azoniabicyclo[3.2.1]octan-3-yl] 2-propylpentanoate;bromide
IUPAC Name
[(1S,5R)-8,8-dimethyl-8-azoniabicyclo[3.2.1]octan-3-yl] 2-propylpentanoate;bromide
Molecular Formula
C17H32BrNO2
Canonical SMILES
CCCC(CCC)C(=O)OC1CC2CCC(C1)[N+]2(C)C.[Br-]
InChI
InChI=1S/C17H32NO2.BrH/c1-5-7-13(8-6-2)17(19)20-16-11-14-9-10-15(12-16)18(14,3)4;/h13-16H,5-12H2,1-4H3;1H/q+1;/p-1/t14-,15+,16?;
InChIKey
QSFKGMJOKUZAJM-JXMYBXCISA-M
Solubility
Soluble in DMSO
Definition
ChEBI: A quaternary ammonium salt resulting from the reaction of the amino group of anisotropine with methyl bromide.
Risk Statements
20/21/22-50/53
Safety Statements
36-61-60
Stability
Stable in light, Heat, & air
Uses
Anisotropine Methylbromide is a antichloindergic agent and has been used for relief of gastrointestinal spasm and for the suppression of gastric acid secretion. Anisotropine Methylbromide was found to be potentially useful in the treatment of duodenal ulcer disease.